nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Rosuvastatin—atherosclerosis	0.0622	0.124	CbGbCtD
Boceprevir—CYP3A5—Simvastatin—atherosclerosis	0.0578	0.116	CbGbCtD
Boceprevir—CYP3A5—Pravastatin—atherosclerosis	0.0566	0.113	CbGbCtD
Boceprevir—CYP3A5—Lovastatin—atherosclerosis	0.0566	0.113	CbGbCtD
Boceprevir—ABCB1—Ezetimibe—atherosclerosis	0.0405	0.0809	CbGbCtD
Boceprevir—ABCB1—Simvastatin—atherosclerosis	0.0376	0.0752	CbGbCtD
Boceprevir—ABCB1—Lovastatin—atherosclerosis	0.0368	0.0736	CbGbCtD
Boceprevir—ABCB1—Pravastatin—atherosclerosis	0.0368	0.0736	CbGbCtD
Boceprevir—CMA1—tunica intima—atherosclerosis	0.0273	0.237	CbGeAlD
Boceprevir—CYP3A4—Rosuvastatin—atherosclerosis	0.0242	0.0485	CbGbCtD
Boceprevir—CYP3A4—Ezetimibe—atherosclerosis	0.0242	0.0485	CbGbCtD
Boceprevir—CYP3A4—Simvastatin—atherosclerosis	0.0225	0.0451	CbGbCtD
Boceprevir—CYP3A4—Pravastatin—atherosclerosis	0.0221	0.0441	CbGbCtD
Boceprevir—CYP3A4—Lovastatin—atherosclerosis	0.0221	0.0441	CbGbCtD
Boceprevir—CTSK—leg—atherosclerosis	0.011	0.0955	CbGeAlD
Boceprevir—CTSK—hindlimb—atherosclerosis	0.00981	0.0853	CbGeAlD
Boceprevir—CMA1—artery—atherosclerosis	0.00933	0.0811	CbGeAlD
Boceprevir—CTSK—appendage—atherosclerosis	0.00841	0.0731	CbGeAlD
Boceprevir—CMA1—blood vessel—atherosclerosis	0.00727	0.0632	CbGeAlD
Boceprevir—CMA1—connective tissue—atherosclerosis	0.00373	0.0324	CbGeAlD
Boceprevir—CMA1—cardiovascular system—atherosclerosis	0.00324	0.0282	CbGeAlD
Boceprevir—CTSL—connective tissue—atherosclerosis	0.00319	0.0277	CbGeAlD
Boceprevir—CTSV—adipose tissue—atherosclerosis	0.00299	0.026	CbGeAlD
Boceprevir—CMA1—adipose tissue—atherosclerosis	0.00286	0.0249	CbGeAlD
Boceprevir—CTSL—cardiovascular system—atherosclerosis	0.00277	0.0241	CbGeAlD
Boceprevir—CTSL—adipose tissue—atherosclerosis	0.00244	0.0213	CbGeAlD
Boceprevir—CTSK—connective tissue—atherosclerosis	0.0024	0.0209	CbGeAlD
Boceprevir—CTSS—connective tissue—atherosclerosis	0.0021	0.0183	CbGeAlD
Boceprevir—CTSK—cardiovascular system—atherosclerosis	0.00209	0.0182	CbGeAlD
Boceprevir—CMA1—liver—atherosclerosis	0.002	0.0174	CbGeAlD
Boceprevir—Telaprevir—ALB—atherosclerosis	0.00194	1	CrCbGaD
Boceprevir—CTSK—adipose tissue—atherosclerosis	0.00184	0.016	CbGeAlD
Boceprevir—CTSS—cardiovascular system—atherosclerosis	0.00183	0.0159	CbGeAlD
Boceprevir—CTSL—liver—atherosclerosis	0.00171	0.0149	CbGeAlD
Boceprevir—CTSS—adipose tissue—atherosclerosis	0.00161	0.014	CbGeAlD
Boceprevir—CTSK—liver—atherosclerosis	0.00129	0.0112	CbGeAlD
Boceprevir—CTSS—liver—atherosclerosis	0.00113	0.00984	CbGeAlD
Boceprevir—ABCB1—blood vessel—atherosclerosis	0.000724	0.00629	CbGeAlD
Boceprevir—CYP3A5—adipose tissue—atherosclerosis	0.000536	0.00466	CbGeAlD
Boceprevir—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000399	0.00201	CcSEcCtD
Boceprevir—Vision blurred—Lovastatin—atherosclerosis	0.000399	0.00201	CcSEcCtD
Boceprevir—Mental disorder—Simvastatin—atherosclerosis	0.000398	0.00201	CcSEcCtD
Boceprevir—Visual impairment—Pravastatin—atherosclerosis	0.000396	0.002	CcSEcCtD
Boceprevir—Erythema—Simvastatin—atherosclerosis	0.000396	0.002	CcSEcCtD
Boceprevir—Ill-defined disorder—Lovastatin—atherosclerosis	0.000392	0.00198	CcSEcCtD
Boceprevir—Eye disorder—Niacin—atherosclerosis	0.00039	0.00197	CcSEcCtD
Boceprevir—Flatulence—Simvastatin—atherosclerosis	0.00039	0.00197	CcSEcCtD
Boceprevir—Tinnitus—Niacin—atherosclerosis	0.000389	0.00196	CcSEcCtD
Boceprevir—Erythema multiforme—Pravastatin—atherosclerosis	0.000388	0.00196	CcSEcCtD
Boceprevir—Dysgeusia—Simvastatin—atherosclerosis	0.000387	0.00196	CcSEcCtD
Boceprevir—Flushing—Niacin—atherosclerosis	0.000387	0.00196	CcSEcCtD
Boceprevir—Angioedema—Lovastatin—atherosclerosis	0.000386	0.00195	CcSEcCtD
Boceprevir—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000385	0.00194	CcSEcCtD
Boceprevir—Anaemia—Ezetimibe—atherosclerosis	0.000383	0.00194	CcSEcCtD
Boceprevir—Tinnitus—Pravastatin—atherosclerosis	0.000383	0.00193	CcSEcCtD
Boceprevir—Malaise—Lovastatin—atherosclerosis	0.000381	0.00193	CcSEcCtD
Boceprevir—Flushing—Pravastatin—atherosclerosis	0.000381	0.00193	CcSEcCtD
Boceprevir—Cardiac disorder—Pravastatin—atherosclerosis	0.000381	0.00193	CcSEcCtD
Boceprevir—Muscle spasms—Simvastatin—atherosclerosis	0.00038	0.00192	CcSEcCtD
Boceprevir—Vertigo—Lovastatin—atherosclerosis	0.00038	0.00192	CcSEcCtD
Boceprevir—Angioedema—Ezetimibe—atherosclerosis	0.000379	0.00191	CcSEcCtD
Boceprevir—Angiopathy—Niacin—atherosclerosis	0.000379	0.00191	CcSEcCtD
Boceprevir—Leukopenia—Lovastatin—atherosclerosis	0.000379	0.00191	CcSEcCtD
Boceprevir—CYP3A5—liver—atherosclerosis	0.000376	0.00327	CbGeAlD
Boceprevir—Chills—Niacin—atherosclerosis	0.000374	0.00189	CcSEcCtD
Boceprevir—Malaise—Ezetimibe—atherosclerosis	0.000374	0.00189	CcSEcCtD
Boceprevir—Vision blurred—Simvastatin—atherosclerosis	0.000373	0.00188	CcSEcCtD
Boceprevir—Arrhythmia—Niacin—atherosclerosis	0.000373	0.00188	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000371	0.00187	CcSEcCtD
Boceprevir—Alopecia—Niacin—atherosclerosis	0.000369	0.00186	CcSEcCtD
Boceprevir—Chills—Pravastatin—atherosclerosis	0.000369	0.00186	CcSEcCtD
Boceprevir—Insomnia—Rosuvastatin—atherosclerosis	0.000368	0.00186	CcSEcCtD
Boceprevir—Ill-defined disorder—Simvastatin—atherosclerosis	0.000367	0.00185	CcSEcCtD
Boceprevir—Arrhythmia—Pravastatin—atherosclerosis	0.000367	0.00185	CcSEcCtD
Boceprevir—Palpitations—Ezetimibe—atherosclerosis	0.000367	0.00185	CcSEcCtD
Boceprevir—Paraesthesia—Rosuvastatin—atherosclerosis	0.000366	0.00185	CcSEcCtD
Boceprevir—Anaemia—Simvastatin—atherosclerosis	0.000366	0.00185	CcSEcCtD
Boceprevir—Malnutrition—Niacin—atherosclerosis	0.000363	0.00183	CcSEcCtD
Boceprevir—Erythema—Niacin—atherosclerosis	0.000363	0.00183	CcSEcCtD
Boceprevir—Alopecia—Pravastatin—atherosclerosis	0.000363	0.00183	CcSEcCtD
Boceprevir—Cough—Ezetimibe—atherosclerosis	0.000362	0.00183	CcSEcCtD
Boceprevir—Angioedema—Simvastatin—atherosclerosis	0.000361	0.00183	CcSEcCtD
Boceprevir—Arthralgia—Lovastatin—atherosclerosis	0.00036	0.00182	CcSEcCtD
Boceprevir—Myalgia—Lovastatin—atherosclerosis	0.00036	0.00182	CcSEcCtD
Boceprevir—Chest pain—Lovastatin—atherosclerosis	0.00036	0.00182	CcSEcCtD
Boceprevir—Anxiety—Lovastatin—atherosclerosis	0.000359	0.00181	CcSEcCtD
Boceprevir—Dyspepsia—Rosuvastatin—atherosclerosis	0.000359	0.00181	CcSEcCtD
Boceprevir—Hypertension—Ezetimibe—atherosclerosis	0.000358	0.00181	CcSEcCtD
Boceprevir—Flatulence—Niacin—atherosclerosis	0.000358	0.00181	CcSEcCtD
Boceprevir—Malaise—Simvastatin—atherosclerosis	0.000357	0.0018	CcSEcCtD
Boceprevir—Discomfort—Lovastatin—atherosclerosis	0.000356	0.0018	CcSEcCtD
Boceprevir—Vertigo—Simvastatin—atherosclerosis	0.000355	0.00179	CcSEcCtD
Boceprevir—Leukopenia—Simvastatin—atherosclerosis	0.000354	0.00179	CcSEcCtD
Boceprevir—Arthralgia—Ezetimibe—atherosclerosis	0.000353	0.00178	CcSEcCtD
Boceprevir—Chest pain—Ezetimibe—atherosclerosis	0.000353	0.00178	CcSEcCtD
Boceprevir—Myalgia—Ezetimibe—atherosclerosis	0.000353	0.00178	CcSEcCtD
Boceprevir—Flatulence—Pravastatin—atherosclerosis	0.000352	0.00178	CcSEcCtD
Boceprevir—Dry mouth—Lovastatin—atherosclerosis	0.000352	0.00178	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000351	0.00177	CcSEcCtD
Boceprevir—Dysgeusia—Pravastatin—atherosclerosis	0.00035	0.00177	CcSEcCtD
Boceprevir—Muscle spasms—Niacin—atherosclerosis	0.000349	0.00176	CcSEcCtD
Boceprevir—Discomfort—Ezetimibe—atherosclerosis	0.000349	0.00176	CcSEcCtD
Boceprevir—Pain—Rosuvastatin—atherosclerosis	0.000348	0.00176	CcSEcCtD
Boceprevir—Constipation—Rosuvastatin—atherosclerosis	0.000348	0.00176	CcSEcCtD
Boceprevir—Confusional state—Lovastatin—atherosclerosis	0.000348	0.00176	CcSEcCtD
Boceprevir—Dry mouth—Ezetimibe—atherosclerosis	0.000345	0.00174	CcSEcCtD
Boceprevir—Muscle spasms—Pravastatin—atherosclerosis	0.000344	0.00174	CcSEcCtD
Boceprevir—Infection—Lovastatin—atherosclerosis	0.000343	0.00173	CcSEcCtD
Boceprevir—Vision blurred—Niacin—atherosclerosis	0.000342	0.00173	CcSEcCtD
Boceprevir—Confusional state—Ezetimibe—atherosclerosis	0.000341	0.00172	CcSEcCtD
Boceprevir—Thrombocytopenia—Lovastatin—atherosclerosis	0.000338	0.00171	CcSEcCtD
Boceprevir—Vision blurred—Pravastatin—atherosclerosis	0.000337	0.0017	CcSEcCtD
Boceprevir—Arthralgia—Simvastatin—atherosclerosis	0.000337	0.0017	CcSEcCtD
Boceprevir—Myalgia—Simvastatin—atherosclerosis	0.000337	0.0017	CcSEcCtD
Boceprevir—Chest pain—Simvastatin—atherosclerosis	0.000337	0.0017	CcSEcCtD
Boceprevir—Infection—Ezetimibe—atherosclerosis	0.000336	0.0017	CcSEcCtD
Boceprevir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000336	0.0017	CcSEcCtD
Boceprevir—Anxiety—Simvastatin—atherosclerosis	0.000336	0.00169	CcSEcCtD
Boceprevir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000333	0.00168	CcSEcCtD
Boceprevir—Discomfort—Simvastatin—atherosclerosis	0.000333	0.00168	CcSEcCtD
Boceprevir—Nervous system disorder—Ezetimibe—atherosclerosis	0.000332	0.00168	CcSEcCtD
Boceprevir—Angioedema—Niacin—atherosclerosis	0.000332	0.00168	CcSEcCtD
Boceprevir—Ill-defined disorder—Pravastatin—atherosclerosis	0.000332	0.00168	CcSEcCtD
Boceprevir—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000331	0.00167	CcSEcCtD
Boceprevir—Anaemia—Pravastatin—atherosclerosis	0.000331	0.00167	CcSEcCtD
Boceprevir—Skin disorder—Ezetimibe—atherosclerosis	0.000329	0.00166	CcSEcCtD
Boceprevir—Angioedema—Pravastatin—atherosclerosis	0.000327	0.00165	CcSEcCtD
Boceprevir—Vertigo—Niacin—atherosclerosis	0.000326	0.00165	CcSEcCtD
Boceprevir—Syncope—Niacin—atherosclerosis	0.000326	0.00165	CcSEcCtD
Boceprevir—Confusional state—Simvastatin—atherosclerosis	0.000326	0.00164	CcSEcCtD
Boceprevir—Leukopenia—Niacin—atherosclerosis	0.000325	0.00164	CcSEcCtD
Boceprevir—Urticaria—Rosuvastatin—atherosclerosis	0.000324	0.00163	CcSEcCtD
Boceprevir—ABCB1—cardiovascular system—atherosclerosis	0.000323	0.00281	CbGeAlD
Boceprevir—Malaise—Pravastatin—atherosclerosis	0.000323	0.00163	CcSEcCtD
Boceprevir—Abdominal pain—Rosuvastatin—atherosclerosis	0.000322	0.00163	CcSEcCtD
Boceprevir—Vertigo—Pravastatin—atherosclerosis	0.000321	0.00162	CcSEcCtD
Boceprevir—Palpitations—Niacin—atherosclerosis	0.000321	0.00162	CcSEcCtD
Boceprevir—Infection—Simvastatin—atherosclerosis	0.000321	0.00162	CcSEcCtD
Boceprevir—Leukopenia—Pravastatin—atherosclerosis	0.00032	0.00162	CcSEcCtD
Boceprevir—Loss of consciousness—Niacin—atherosclerosis	0.000319	0.00161	CcSEcCtD
Boceprevir—Cough—Niacin—atherosclerosis	0.000317	0.0016	CcSEcCtD
Boceprevir—Thrombocytopenia—Simvastatin—atherosclerosis	0.000316	0.0016	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000314	0.00159	CcSEcCtD
Boceprevir—Insomnia—Lovastatin—atherosclerosis	0.000312	0.00158	CcSEcCtD
Boceprevir—Cough—Pravastatin—atherosclerosis	0.000312	0.00158	CcSEcCtD
Boceprevir—Paraesthesia—Lovastatin—atherosclerosis	0.00031	0.00157	CcSEcCtD
Boceprevir—Arthralgia—Niacin—atherosclerosis	0.000309	0.00156	CcSEcCtD
Boceprevir—Myalgia—Niacin—atherosclerosis	0.000309	0.00156	CcSEcCtD
Boceprevir—Hypertension—Pravastatin—atherosclerosis	0.000309	0.00156	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000308	0.00156	CcSEcCtD
Boceprevir—Dyspnoea—Lovastatin—atherosclerosis	0.000308	0.00155	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000307	0.00155	CcSEcCtD
Boceprevir—Insomnia—Ezetimibe—atherosclerosis	0.000306	0.00155	CcSEcCtD
Boceprevir—Chest pain—Pravastatin—atherosclerosis	0.000304	0.00154	CcSEcCtD
Boceprevir—Arthralgia—Pravastatin—atherosclerosis	0.000304	0.00154	CcSEcCtD
Boceprevir—Myalgia—Pravastatin—atherosclerosis	0.000304	0.00154	CcSEcCtD
Boceprevir—Paraesthesia—Ezetimibe—atherosclerosis	0.000304	0.00154	CcSEcCtD
Boceprevir—Dyspepsia—Lovastatin—atherosclerosis	0.000304	0.00153	CcSEcCtD
Boceprevir—Anxiety—Pravastatin—atherosclerosis	0.000303	0.00153	CcSEcCtD
Boceprevir—Dry mouth—Niacin—atherosclerosis	0.000302	0.00153	CcSEcCtD
Boceprevir—Dyspnoea—Ezetimibe—atherosclerosis	0.000302	0.00152	CcSEcCtD
Boceprevir—Discomfort—Pravastatin—atherosclerosis	0.000301	0.00152	CcSEcCtD
Boceprevir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0003	0.00152	CcSEcCtD
Boceprevir—Decreased appetite—Lovastatin—atherosclerosis	0.0003	0.00152	CcSEcCtD
Boceprevir—Dyspepsia—Ezetimibe—atherosclerosis	0.000298	0.00151	CcSEcCtD
Boceprevir—Fatigue—Lovastatin—atherosclerosis	0.000298	0.0015	CcSEcCtD
Boceprevir—Constipation—Lovastatin—atherosclerosis	0.000295	0.00149	CcSEcCtD
Boceprevir—Pain—Lovastatin—atherosclerosis	0.000295	0.00149	CcSEcCtD
Boceprevir—Confusional state—Pravastatin—atherosclerosis	0.000294	0.00149	CcSEcCtD
Boceprevir—Decreased appetite—Ezetimibe—atherosclerosis	0.000294	0.00149	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000294	0.00149	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000292	0.00148	CcSEcCtD
Boceprevir—Asthenia—Rosuvastatin—atherosclerosis	0.000292	0.00148	CcSEcCtD
Boceprevir—Insomnia—Simvastatin—atherosclerosis	0.000292	0.00147	CcSEcCtD
Boceprevir—Fatigue—Ezetimibe—atherosclerosis	0.000292	0.00147	CcSEcCtD
Boceprevir—Shock—Niacin—atherosclerosis	0.000292	0.00147	CcSEcCtD
Boceprevir—Infection—Pravastatin—atherosclerosis	0.00029	0.00146	CcSEcCtD
Boceprevir—Paraesthesia—Simvastatin—atherosclerosis	0.00029	0.00146	CcSEcCtD
Boceprevir—Pain—Ezetimibe—atherosclerosis	0.000289	0.00146	CcSEcCtD
Boceprevir—Constipation—Ezetimibe—atherosclerosis	0.000289	0.00146	CcSEcCtD
Boceprevir—Tachycardia—Niacin—atherosclerosis	0.000289	0.00146	CcSEcCtD
Boceprevir—Pruritus—Rosuvastatin—atherosclerosis	0.000288	0.00146	CcSEcCtD
Boceprevir—Skin disorder—Niacin—atherosclerosis	0.000288	0.00145	CcSEcCtD
Boceprevir—Dyspnoea—Simvastatin—atherosclerosis	0.000288	0.00145	CcSEcCtD
Boceprevir—Hyperhidrosis—Niacin—atherosclerosis	0.000287	0.00145	CcSEcCtD
Boceprevir—Thrombocytopenia—Pravastatin—atherosclerosis	0.000286	0.00144	CcSEcCtD
Boceprevir—ABCB1—adipose tissue—atherosclerosis	0.000285	0.00248	CbGeAlD
Boceprevir—Feeling abnormal—Lovastatin—atherosclerosis	0.000284	0.00144	CcSEcCtD
Boceprevir—Dyspepsia—Simvastatin—atherosclerosis	0.000284	0.00144	CcSEcCtD
Boceprevir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000282	0.00143	CcSEcCtD
Boceprevir—Hyperhidrosis—Pravastatin—atherosclerosis	0.000282	0.00143	CcSEcCtD
Boceprevir—CYP3A4—liver—atherosclerosis	0.000282	0.00245	CbGeAlD
Boceprevir—Decreased appetite—Simvastatin—atherosclerosis	0.000281	0.00142	CcSEcCtD
Boceprevir—Feeling abnormal—Ezetimibe—atherosclerosis	0.000279	0.00141	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000279	0.00141	CcSEcCtD
Boceprevir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000279	0.00141	CcSEcCtD
Boceprevir—Fatigue—Simvastatin—atherosclerosis	0.000278	0.00141	CcSEcCtD
Boceprevir—Hypotension—Niacin—atherosclerosis	0.000277	0.0014	CcSEcCtD
Boceprevir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000277	0.0014	CcSEcCtD
Boceprevir—Constipation—Simvastatin—atherosclerosis	0.000276	0.00139	CcSEcCtD
Boceprevir—Pain—Simvastatin—atherosclerosis	0.000276	0.00139	CcSEcCtD
Boceprevir—Urticaria—Lovastatin—atherosclerosis	0.000274	0.00138	CcSEcCtD
Boceprevir—Abdominal pain—Lovastatin—atherosclerosis	0.000273	0.00138	CcSEcCtD
Boceprevir—Body temperature increased—Lovastatin—atherosclerosis	0.000273	0.00138	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00027	0.00136	CcSEcCtD
Boceprevir—Dizziness—Rosuvastatin—atherosclerosis	0.000269	0.00136	CcSEcCtD
Boceprevir—Urticaria—Ezetimibe—atherosclerosis	0.000269	0.00136	CcSEcCtD
Boceprevir—Insomnia—Niacin—atherosclerosis	0.000268	0.00135	CcSEcCtD
Boceprevir—Body temperature increased—Ezetimibe—atherosclerosis	0.000268	0.00135	CcSEcCtD
Boceprevir—Abdominal pain—Ezetimibe—atherosclerosis	0.000268	0.00135	CcSEcCtD
Boceprevir—Paraesthesia—Niacin—atherosclerosis	0.000266	0.00134	CcSEcCtD
Boceprevir—Feeling abnormal—Simvastatin—atherosclerosis	0.000266	0.00134	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000266	0.00134	CcSEcCtD
Boceprevir—Dyspnoea—Niacin—atherosclerosis	0.000264	0.00133	CcSEcCtD
Boceprevir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000264	0.00133	CcSEcCtD
Boceprevir—Insomnia—Pravastatin—atherosclerosis	0.000264	0.00133	CcSEcCtD
Boceprevir—Paraesthesia—Pravastatin—atherosclerosis	0.000262	0.00132	CcSEcCtD
Boceprevir—Dyspepsia—Niacin—atherosclerosis	0.000261	0.00132	CcSEcCtD
Boceprevir—Dyspnoea—Pravastatin—atherosclerosis	0.00026	0.00131	CcSEcCtD
Boceprevir—Decreased appetite—Niacin—atherosclerosis	0.000258	0.0013	CcSEcCtD
Boceprevir—Dyspepsia—Pravastatin—atherosclerosis	0.000257	0.0013	CcSEcCtD
Boceprevir—Rash—Rosuvastatin—atherosclerosis	0.000257	0.0013	CcSEcCtD
Boceprevir—Dermatitis—Rosuvastatin—atherosclerosis	0.000257	0.0013	CcSEcCtD
Boceprevir—Urticaria—Simvastatin—atherosclerosis	0.000256	0.0013	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Niacin—atherosclerosis	0.000256	0.00129	CcSEcCtD
Boceprevir—Abdominal pain—Simvastatin—atherosclerosis	0.000255	0.00129	CcSEcCtD
Boceprevir—Body temperature increased—Simvastatin—atherosclerosis	0.000255	0.00129	CcSEcCtD
Boceprevir—Headache—Rosuvastatin—atherosclerosis	0.000255	0.00129	CcSEcCtD
Boceprevir—Hypersensitivity—Lovastatin—atherosclerosis	0.000254	0.00128	CcSEcCtD
Boceprevir—Decreased appetite—Pravastatin—atherosclerosis	0.000254	0.00128	CcSEcCtD
Boceprevir—Pain—Niacin—atherosclerosis	0.000253	0.00128	CcSEcCtD
Boceprevir—Fatigue—Pravastatin—atherosclerosis	0.000252	0.00127	CcSEcCtD
Boceprevir—Pain—Pravastatin—atherosclerosis	0.00025	0.00126	CcSEcCtD
Boceprevir—Constipation—Pravastatin—atherosclerosis	0.00025	0.00126	CcSEcCtD
Boceprevir—Hypersensitivity—Ezetimibe—atherosclerosis	0.000249	0.00126	CcSEcCtD
Boceprevir—Asthenia—Lovastatin—atherosclerosis	0.000248	0.00125	CcSEcCtD
Boceprevir—Pruritus—Lovastatin—atherosclerosis	0.000244	0.00123	CcSEcCtD
Boceprevir—Asthenia—Ezetimibe—atherosclerosis	0.000243	0.00123	CcSEcCtD
Boceprevir—Gastrointestinal pain—Niacin—atherosclerosis	0.000242	0.00122	CcSEcCtD
Boceprevir—Nausea—Rosuvastatin—atherosclerosis	0.000242	0.00122	CcSEcCtD
Boceprevir—Feeling abnormal—Pravastatin—atherosclerosis	0.000241	0.00121	CcSEcCtD
Boceprevir—Pruritus—Ezetimibe—atherosclerosis	0.00024	0.00121	CcSEcCtD
Boceprevir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000239	0.00121	CcSEcCtD
Boceprevir—Hypersensitivity—Simvastatin—atherosclerosis	0.000238	0.0012	CcSEcCtD
Boceprevir—Diarrhoea—Lovastatin—atherosclerosis	0.000236	0.00119	CcSEcCtD
Boceprevir—Urticaria—Niacin—atherosclerosis	0.000235	0.00119	CcSEcCtD
Boceprevir—Abdominal pain—Niacin—atherosclerosis	0.000234	0.00118	CcSEcCtD
Boceprevir—Body temperature increased—Niacin—atherosclerosis	0.000234	0.00118	CcSEcCtD
Boceprevir—Urticaria—Pravastatin—atherosclerosis	0.000232	0.00117	CcSEcCtD
Boceprevir—Asthenia—Simvastatin—atherosclerosis	0.000232	0.00117	CcSEcCtD
Boceprevir—Diarrhoea—Ezetimibe—atherosclerosis	0.000232	0.00117	CcSEcCtD
Boceprevir—Abdominal pain—Pravastatin—atherosclerosis	0.000231	0.00117	CcSEcCtD
Boceprevir—Body temperature increased—Pravastatin—atherosclerosis	0.000231	0.00117	CcSEcCtD
Boceprevir—Pruritus—Simvastatin—atherosclerosis	0.000228	0.00115	CcSEcCtD
Boceprevir—Dizziness—Lovastatin—atherosclerosis	0.000228	0.00115	CcSEcCtD
Boceprevir—Dizziness—Ezetimibe—atherosclerosis	0.000224	0.00113	CcSEcCtD
Boceprevir—Diarrhoea—Simvastatin—atherosclerosis	0.000221	0.00112	CcSEcCtD
Boceprevir—Vomiting—Lovastatin—atherosclerosis	0.000219	0.00111	CcSEcCtD
Boceprevir—Hypersensitivity—Niacin—atherosclerosis	0.000218	0.0011	CcSEcCtD
Boceprevir—Rash—Lovastatin—atherosclerosis	0.000218	0.0011	CcSEcCtD
Boceprevir—Dermatitis—Lovastatin—atherosclerosis	0.000217	0.0011	CcSEcCtD
Boceprevir—Headache—Lovastatin—atherosclerosis	0.000216	0.00109	CcSEcCtD
Boceprevir—Vomiting—Ezetimibe—atherosclerosis	0.000215	0.00109	CcSEcCtD
Boceprevir—Hypersensitivity—Pravastatin—atherosclerosis	0.000215	0.00109	CcSEcCtD
Boceprevir—Dizziness—Simvastatin—atherosclerosis	0.000213	0.00108	CcSEcCtD
Boceprevir—Rash—Ezetimibe—atherosclerosis	0.000213	0.00108	CcSEcCtD
Boceprevir—Dermatitis—Ezetimibe—atherosclerosis	0.000213	0.00108	CcSEcCtD
Boceprevir—Asthenia—Niacin—atherosclerosis	0.000213	0.00107	CcSEcCtD
Boceprevir—Headache—Ezetimibe—atherosclerosis	0.000212	0.00107	CcSEcCtD
Boceprevir—Pruritus—Niacin—atherosclerosis	0.00021	0.00106	CcSEcCtD
Boceprevir—Asthenia—Pravastatin—atherosclerosis	0.000209	0.00106	CcSEcCtD
Boceprevir—Pruritus—Pravastatin—atherosclerosis	0.000206	0.00104	CcSEcCtD
Boceprevir—Vomiting—Simvastatin—atherosclerosis	0.000205	0.00104	CcSEcCtD
Boceprevir—Nausea—Lovastatin—atherosclerosis	0.000205	0.00104	CcSEcCtD
Boceprevir—Rash—Simvastatin—atherosclerosis	0.000204	0.00103	CcSEcCtD
Boceprevir—Dermatitis—Simvastatin—atherosclerosis	0.000203	0.00103	CcSEcCtD
Boceprevir—Diarrhoea—Niacin—atherosclerosis	0.000203	0.00102	CcSEcCtD
Boceprevir—Headache—Simvastatin—atherosclerosis	0.000202	0.00102	CcSEcCtD
Boceprevir—Nausea—Ezetimibe—atherosclerosis	0.000201	0.00102	CcSEcCtD
Boceprevir—ABCB1—liver—atherosclerosis	0.0002	0.00174	CbGeAlD
Boceprevir—Diarrhoea—Pravastatin—atherosclerosis	0.0002	0.00101	CcSEcCtD
Boceprevir—Dizziness—Niacin—atherosclerosis	0.000196	0.00099	CcSEcCtD
Boceprevir—Dizziness—Pravastatin—atherosclerosis	0.000193	0.000975	CcSEcCtD
Boceprevir—Nausea—Simvastatin—atherosclerosis	0.000192	0.000968	CcSEcCtD
Boceprevir—Vomiting—Niacin—atherosclerosis	0.000188	0.000952	CcSEcCtD
Boceprevir—Rash—Niacin—atherosclerosis	0.000187	0.000944	CcSEcCtD
Boceprevir—Dermatitis—Niacin—atherosclerosis	0.000187	0.000943	CcSEcCtD
Boceprevir—Headache—Niacin—atherosclerosis	0.000186	0.000938	CcSEcCtD
Boceprevir—Vomiting—Pravastatin—atherosclerosis	0.000186	0.000937	CcSEcCtD
Boceprevir—Rash—Pravastatin—atherosclerosis	0.000184	0.000929	CcSEcCtD
Boceprevir—Dermatitis—Pravastatin—atherosclerosis	0.000184	0.000929	CcSEcCtD
Boceprevir—Headache—Pravastatin—atherosclerosis	0.000183	0.000923	CcSEcCtD
Boceprevir—Nausea—Niacin—atherosclerosis	0.000176	0.000889	CcSEcCtD
Boceprevir—Nausea—Pravastatin—atherosclerosis	0.000173	0.000876	CcSEcCtD
Boceprevir—CTSS—Immune System—CRP—atherosclerosis	4.49e-05	0.000242	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PRKCG—atherosclerosis	4.49e-05	0.000242	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NFKB1—atherosclerosis	4.48e-05	0.000242	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK8—atherosclerosis	4.41e-05	0.000238	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SPP1—atherosclerosis	4.37e-05	0.000236	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IFNG—atherosclerosis	4.36e-05	0.000235	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NFKB1—atherosclerosis	4.3e-05	0.000233	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR4—atherosclerosis	4.3e-05	0.000232	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—atherosclerosis	4.12e-05	0.000223	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—atherosclerosis	4.12e-05	0.000223	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ICAM1—atherosclerosis	4.12e-05	0.000223	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—atherosclerosis	4.1e-05	0.000222	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—atherosclerosis	4.1e-05	0.000222	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	4.05e-05	0.000219	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFB—atherosclerosis	4.04e-05	0.000218	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AGT—atherosclerosis	3.95e-05	0.000213	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—atherosclerosis	3.89e-05	0.00021	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	3.88e-05	0.00021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LEP—atherosclerosis	3.87e-05	0.000209	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—atherosclerosis	3.87e-05	0.000209	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK3—atherosclerosis	3.85e-05	0.000208	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CAV1—atherosclerosis	3.83e-05	0.000207	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NFKB1—atherosclerosis	3.83e-05	0.000207	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NFKB1—atherosclerosis	3.83e-05	0.000207	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOA1—atherosclerosis	3.82e-05	0.000207	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	3.81e-05	0.000206	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—atherosclerosis	3.81e-05	0.000206	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—atherosclerosis	3.8e-05	0.000206	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—atherosclerosis	3.8e-05	0.000206	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	3.8e-05	0.000205	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK8—atherosclerosis	3.76e-05	0.000203	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK8—atherosclerosis	3.76e-05	0.000203	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LDLRAP1—atherosclerosis	3.74e-05	0.000202	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ESR1—atherosclerosis	3.69e-05	0.0002	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—atherosclerosis	3.65e-05	0.000197	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—atherosclerosis	3.65e-05	0.000197	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—F2—atherosclerosis	3.65e-05	0.000197	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.52e-05	0.00019	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLTP—atherosclerosis	3.51e-05	0.00019	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CG—atherosclerosis	3.49e-05	0.000189	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—atherosclerosis	3.44e-05	0.000186	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—atherosclerosis	3.44e-05	0.000186	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—atherosclerosis	3.42e-05	0.000185	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	3.4e-05	0.000184	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—atherosclerosis	3.4e-05	0.000184	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—INS—atherosclerosis	3.3e-05	0.000179	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	3.29e-05	0.000178	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK3—atherosclerosis	3.29e-05	0.000178	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK3—atherosclerosis	3.29e-05	0.000178	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—atherosclerosis	3.25e-05	0.000176	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1—atherosclerosis	3.2e-05	0.000173	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NFKB1—atherosclerosis	3.17e-05	0.000171	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.16e-05	0.000171	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—atherosclerosis	3.15e-05	0.00017	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—atherosclerosis	3.14e-05	0.00017	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK8—atherosclerosis	3.12e-05	0.000168	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG8—atherosclerosis	3.05e-05	0.000165	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LTA4H—atherosclerosis	3.05e-05	0.000165	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.04e-05	0.000164	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SERPINE1—atherosclerosis	3.03e-05	0.000164	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—atherosclerosis	3.03e-05	0.000164	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	3.02e-05	0.000163	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOS3—atherosclerosis	2.9e-05	0.000157	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	2.87e-05	0.000155	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—atherosclerosis	2.85e-05	0.000154	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—atherosclerosis	2.82e-05	0.000152	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDLRAP1—atherosclerosis	2.82e-05	0.000152	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—atherosclerosis	2.81e-05	0.000152	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—atherosclerosis	2.8e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK3—atherosclerosis	2.72e-05	0.000147	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLTP—atherosclerosis	2.65e-05	0.000143	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NFKB1—atherosclerosis	2.61e-05	0.000141	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—atherosclerosis	2.6e-05	0.00014	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—atherosclerosis	2.57e-05	0.000139	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK8—atherosclerosis	2.57e-05	0.000139	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—atherosclerosis	2.49e-05	0.000135	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	2.49e-05	0.000134	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.45e-05	0.000132	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	2.42e-05	0.000131	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2.42e-05	0.000131	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG1—atherosclerosis	2.41e-05	0.00013	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—atherosclerosis	2.4e-05	0.00013	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—atherosclerosis	2.4e-05	0.00013	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—atherosclerosis	2.35e-05	0.000127	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—atherosclerosis	2.32e-05	0.000126	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NFKB1—atherosclerosis	2.3e-05	0.000124	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LTA4H—atherosclerosis	2.3e-05	0.000124	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG8—atherosclerosis	2.3e-05	0.000124	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FABP4—atherosclerosis	2.26e-05	0.000122	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LCAT—atherosclerosis	2.26e-05	0.000122	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK8—atherosclerosis	2.26e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.25e-05	0.000122	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK3—atherosclerosis	2.24e-05	0.000121	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA4—atherosclerosis	2.22e-05	0.00012	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—atherosclerosis	2.22e-05	0.00012	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—atherosclerosis	2.22e-05	0.00012	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP7A1—atherosclerosis	2.18e-05	0.000118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—atherosclerosis	2.09e-05	0.000113	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—atherosclerosis	2.07e-05	0.000112	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.06e-05	0.000111	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP27A1—atherosclerosis	2.02e-05	0.000109	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—atherosclerosis	1.99e-05	0.000108	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.99e-05	0.000107	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK3—atherosclerosis	1.97e-05	0.000107	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—atherosclerosis	1.92e-05	0.000104	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA2—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALOX15—atherosclerosis	1.91e-05	0.000103	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG5—atherosclerosis	1.89e-05	0.000102	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—atherosclerosis	1.84e-05	9.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPA—atherosclerosis	1.82e-05	9.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG1—atherosclerosis	1.82e-05	9.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.79e-05	9.67e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BGN—atherosclerosis	1.77e-05	9.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.76e-05	9.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA5—atherosclerosis	1.75e-05	9.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.74e-05	9.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LCAT—atherosclerosis	1.71e-05	9.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FABP4—atherosclerosis	1.71e-05	9.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.69e-05	9.12e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.68e-05	9.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA4—atherosclerosis	1.68e-05	9.06e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.65e-05	8.9e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—atherosclerosis	1.64e-05	8.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLTP—atherosclerosis	1.63e-05	8.83e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.63e-05	8.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.62e-05	8.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.56e-05	8.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.54e-05	8.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.52e-05	8.23e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—atherosclerosis	1.51e-05	8.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.49e-05	8.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.49e-05	8.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.46e-05	7.88e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LIPC—atherosclerosis	1.45e-05	7.83e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—atherosclerosis	1.44e-05	7.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA2—atherosclerosis	1.44e-05	7.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.44e-05	7.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.44e-05	7.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALOX15—atherosclerosis	1.44e-05	7.8e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOC3—atherosclerosis	1.44e-05	7.78e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LDLR—atherosclerosis	1.43e-05	7.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG5—atherosclerosis	1.43e-05	7.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.42e-05	7.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.42e-05	7.65e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CETP—atherosclerosis	1.4e-05	7.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.39e-05	7.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPA—atherosclerosis	1.38e-05	7.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.34e-05	7.24e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BGN—atherosclerosis	1.33e-05	7.21e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—atherosclerosis	1.33e-05	7.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA5—atherosclerosis	1.32e-05	7.13e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.27e-05	6.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.26e-05	6.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.26e-05	6.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALOX5—atherosclerosis	1.23e-05	6.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.18e-05	6.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.13e-05	6.09e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.12e-05	6.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NAMPT—atherosclerosis	1.1e-05	5.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LIPC—atherosclerosis	1.09e-05	5.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOC3—atherosclerosis	1.09e-05	5.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDLR—atherosclerosis	1.08e-05	5.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CETP—atherosclerosis	1.06e-05	5.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FABP4—atherosclerosis	1.05e-05	5.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LCAT—atherosclerosis	1.05e-05	5.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.04e-05	5.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA4—atherosclerosis	1.03e-05	5.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.01e-05	5.48e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SCARB1—atherosclerosis	1.01e-05	5.46e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—atherosclerosis	9.67e-06	5.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMGCR—atherosclerosis	9.54e-06	5.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.38e-06	5.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.36e-06	5.06e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOB—atherosclerosis	9.27e-06	5.01e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—atherosclerosis	9.01e-06	4.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.89e-06	4.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.89e-06	4.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.89e-06	4.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA2—atherosclerosis	8.89e-06	4.81e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPL—atherosclerosis	8.85e-06	4.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.78e-06	4.75e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—atherosclerosis	8.63e-06	4.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCA1—atherosclerosis	8.51e-06	4.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPA—atherosclerosis	8.48e-06	4.58e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD36—atherosclerosis	8.41e-06	4.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BGN—atherosclerosis	8.22e-06	4.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA5—atherosclerosis	8.13e-06	4.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—atherosclerosis	7.97e-06	4.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.83e-06	4.23e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARA—atherosclerosis	7.81e-06	4.22e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—atherosclerosis	7.57e-06	4.09e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.56e-06	4.09e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—atherosclerosis	7.42e-06	4.01e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—atherosclerosis	7.35e-06	3.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA1—atherosclerosis	7.33e-06	3.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—atherosclerosis	7.3e-06	3.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOB—atherosclerosis	6.99e-06	3.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—atherosclerosis	6.8e-06	3.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.78e-06	3.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LIPC—atherosclerosis	6.74e-06	3.64e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOC3—atherosclerosis	6.7e-06	3.62e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—atherosclerosis	6.69e-06	3.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPL—atherosclerosis	6.68e-06	3.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDLR—atherosclerosis	6.66e-06	3.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—atherosclerosis	6.51e-06	3.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CETP—atherosclerosis	6.5e-06	3.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—atherosclerosis	6.46e-06	3.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD36—atherosclerosis	6.34e-06	3.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INS—atherosclerosis	6.33e-06	3.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.23e-06	3.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—atherosclerosis	6.01e-06	3.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARA—atherosclerosis	5.9e-06	3.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.88e-06	3.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—atherosclerosis	5.81e-06	3.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—atherosclerosis	5.71e-06	3.09e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—atherosclerosis	5.6e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—atherosclerosis	5.56e-06	3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—atherosclerosis	5.54e-06	3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA1—atherosclerosis	5.53e-06	2.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.24e-06	2.83e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.08e-06	2.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.05e-06	2.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—atherosclerosis	4.87e-06	2.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INS—atherosclerosis	4.78e-06	2.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.5e-06	2.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—atherosclerosis	4.38e-06	2.37e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOB—atherosclerosis	4.31e-06	2.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—atherosclerosis	4.19e-06	2.27e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.19e-06	2.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPL—atherosclerosis	4.11e-06	2.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—atherosclerosis	4.01e-06	2.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD36—atherosclerosis	3.91e-06	2.11e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—atherosclerosis	3.83e-06	2.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.7e-06	2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARA—atherosclerosis	3.63e-06	1.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—atherosclerosis	3.52e-06	1.9e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—atherosclerosis	3.45e-06	1.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—atherosclerosis	3.42e-06	1.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA1—atherosclerosis	3.41e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.11e-06	1.68e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—atherosclerosis	3e-06	1.62e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INS—atherosclerosis	2.95e-06	1.59e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—atherosclerosis	2.7e-06	1.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—atherosclerosis	2.58e-06	1.4e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—atherosclerosis	2.55e-06	1.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.36e-06	1.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—atherosclerosis	1.93e-06	1.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—atherosclerosis	1.19e-06	6.42e-06	CbGpPWpGaD
